Therapeutic approach to Alzheimer's disease: current treatments and new perspectives

T Pardo-Moreno, A González-Acedo… - Pharmaceutics, 2022 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia. The pathophysiology of
this disease is characterized by the accumulation of amyloid-β, leading to the formation of …

[HTML][HTML] Multiple nano-drug delivery systems for intervertebral disc degeneration: Current status and future perspectives

W Liu, Z Ma, Y Wang, J Yang - Bioactive Materials, 2023 - Elsevier
Low back pain (LBP) is a common disease that imposes a huge social and economic
burden on people. Intervertebral disc (IVD) degeneration (IVDD) is often considered to be …

[HTML][HTML] Current research trends of nanomedicines

Q Liu, J Zou, Z Chen, W He, W Wu - Acta Pharmaceutica Sinica B, 2023 - Elsevier
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …

Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis

L Li, R He, H Yan, Z Leng, S Zhu, Z Gu - Nano Today, 2022 - Elsevier
As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

Dietary polyphenols as therapeutic intervention for Alzheimer's disease: a mechanistic insight

SNA Bukhari - Antioxidants, 2022 - mdpi.com
Dietary polyphenols encompass a diverse range of secondary metabolites found in nature,
such as fruits, vegetables, herbal teas, wine, and cocoa products, etc. Structurally, they are …

Potential implications of miRNAs in the pathogenesis, diagnosis, and therapeutics of Alzheimer's disease

L Wang, X Shui, Y Diao, D Chen, Y Zhou… - International Journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) is a complex multifactorial disorder that poses a substantial
burden on patients, caregivers, and society. Considering the increased aging population …

Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer

D Sanjanwala, V Patravale - Drug Discovery Today, 2023 - Elsevier
Highlights•Active targeting uses ligands to target drugs to particular tissues or
cells.•Antibodies are commonly used targeting ligands which are bulky and difficult to …

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective

DE Nayab, F Din, H Ali, WA Kausar, S Urooj… - Journal of …, 2023 - Springer
Neurons and their connecting axons gradually degenerate in neurodegenerative diseases
(NDs), leading to dysfunctionality of the neuronal cells and eventually their death. Drug …

Cell membrane-based nanomaterials for therapeutics of neurodegenerative diseases

PT Nguyen-Thi, TT Nguyen, HL Phan, TT Ho… - Neurochemistry …, 2023 - Elsevier
Central nervous system (CNS) diseases such as Alzheimer's disease (AD), Parkinson's
disease (PD), glioblastoma (GBM), and peripheral nerve injury have been documented as …

Recent advancements in nanomaterials: A promising way to manage neurodegenerative disorders

TT Nguyen, PT Nguyen-Thi, THA Nguyen… - Molecular Diagnosis & …, 2023 - Springer
Neurodegenerative diseases (NDs) such as dementia, Alzheimer's disease, Parkinson's
disease, frontotemporal dementia, and amyotrophic lateral sclerosis are some of the most …